BIOLOGICAL · Unmapped registry intervention
AFFITOPE® PD01A + Adjuvant
Find medicine records ·
Find other trials using this name
Clinical trial
Study Assessing Tolerability and Safety and Exploring the Immunogenicity and Therapeutic Activity of AFFITOPE® PD01A in PD-GBA Patients
NCT02758730
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
BIOLOGICAL · Unmapped registry intervention
Adjuvant without active component
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedStudy Assessing Tolerability and Safety and Exploring the Immunogenicity and Therapeutic Activity of AFFITOPE® PD01A in PD-GBA Patients
Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Parkinson's Diseaseverified · MONDO: Parkinson disease
Interventions
AFFITOPE® PD01A + AdjuvantBIOLOGICAL
Adjuvant without active componentBIOLOGICAL
Sponsors & collaborators
Affiris AGlead sponsor
University Hospital Tuebingencollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02758730 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.